Congratulations to Yulong Su for being named a Convergence Scholar for the MIT Center for Precision Cancer Medicine. Yulong’s work strives to address oncogenic transcriptional programs in a variety of cancer types, emphasizing strategies to control the protein levels of oncogenic factors such as MYC. Read more here: https://ki.mit.edu/news/2019/introducing-2019-2020-convergence-scholars
MIT CPCM 2019-2020 ConVergence Scholars
The Koehler Lab aims to innovate in the earliest stages of drug discovery by building chemical tools or technologies to assist in the process of target validation and by expanding the repertoire of protein targets that are considered to be druggable. We focus primarily on building chemical tools and methods for studying temporal aspects of transcriptional regulation in development and disease with a focus on cancer.
The Koehler Lab is supported through the generosity of our public and private funding partners.
We will gladly accommodate requests for greater accessibility of public content.
